Literature DB >> 3150043

Pharmacokinetics of gold sodium thiomalate in rabbits.

S Melethil1, D Schoepp.   

Abstract

Male, New Zealand white rabbits (3.5-4.3 kg) received a single 2-mg/kg dose of gold sodium thiomalate (Myochrysine) via intramuscular (N = 4) and intravenous (N = 3) routes. Blood samples were drawn from the marginal ear vein for a period of 5-10 days. The concentration of gold in whole blood was determined using graphite furnace atomic absorption spectrophotometry. The blood concentration-time profiles obtained following both routes of administration were best described by a two-compartment open model with first-order absorption for the intramuscular route. Gold was absorbed rapidly with a mean (harmonic) absorption half-life of 9.0 min, with a peak concentration of 6.0 +/- 1.0 micrograms/ml (N = 4). Blood concentrations declined in a biphasic manner; the mean alpha half-lives were 0.738 and 1.78 hr for the iv and im routes, respectively. The corresponding terminal (beta) half-lives were 54.1 and 63.0 hr. The estimated volume of the central compartment (70 to 93 ml/kg) agreed closely with the rabbit blood volume. The mean (+/- SD) extent of the dose absorbed following intramuscular injection was 68.9 +/- 12.4%.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3150043     DOI: 10.1023/a:1016453421958

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: S K & F D-30162.

Authors:  D T Walz; M J DiMartino; L W Chakrin; B M Sutton; A MISHER
Journal:  J Pharmacol Exp Ther       Date:  1976-04       Impact factor: 4.030

Review 2.  Intramuscular injections and bioavailability.

Authors:  C B Tuttle
Journal:  Am J Hosp Pharm       Date:  1977-09

Review 3.  Monitoring gold plasma levels in rheumatoid arthritis.

Authors:  A Lorber
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

4.  Problems associated with analysis of pharmacokinetic models.

Authors:  W J Westlake
Journal:  J Pharm Sci       Date:  1971-06       Impact factor: 3.534

5.  Transport of gold in the body.

Authors:  E G McQueen; P W Dykes
Journal:  Ann Rheum Dis       Date:  1969-07       Impact factor: 19.103

6.  Pharmacokinetics of gold sodium thiomalate.

Authors:  E S Waller; J W Massarella; J E Crout; G J Yakatan
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1982-07

7.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

8.  Serum gold levels during chrysotherapy with relation to urinary and fecal excretion.

Authors:  M Harth
Journal:  Clin Pharmacol Ther       Date:  1974-04       Impact factor: 6.875

9.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

10.  Binding of gold to bovine serum albumin using flameless atomic absorption.

Authors:  S Melethil; A Poklis; V A Sagar
Journal:  J Pharm Sci       Date:  1980-05       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.